Showing results (91-100 of 130) with videos related to

Sort By:
Pageof 13
Advances in Radiation Oncology|February 2, 2019
Prostate Stereotactic Body Radiation Therapy With a Focal Simultaneous Integrated Boost: Acute Toxicity and Dosimetry Results From a Prospective TrialAndrew M McDonald, Michael C Dobelbower, Eddy S Yang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 8, 2012
Kinomic profiling approach identifies Trk as a novel radiation modulatorJohn S Jarboe, Jerry J Jaboin, Joshua C Anderson, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 1, 2020
Lipid microsphere bound oxycodone for pain management in patients receiving radiotherapy for head and neck cancerAndrew M McDonald, Sharon A Spencer, Christopher D Willey, et al.
Cancers|July 24, 2021
The BET Inhibitor JQ1 Augments the Antitumor Efficacy of Gemcitabine in Preclinical Models of Pancreatic CancerAubrey L Miller, Patrick L Garcia, Samuel C Fehling, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 20, 2014
The protective effect of p16(INK4a) in oral cavity carcinomas: p16(Ink4A) dampens tumor invasion-integrated analysis of expression and kinomics pathwaysTatyana Isayeva, Jie Xu, Camille Ragin, et al.
Molecular Cancer Therapeutics|June 10, 2021
Gene Expression Signature Correlates with Outcomes in Metastatic Renal Cell Carcinoma Patients Treated with Everolimus Alone or with a Vascular Disrupting AgentEddy S Yang, Amin H Nassar, Elio Adib, et al.
British Journal of Cancer|September 8, 2017
Presurgical weight loss affects tumour traits and circulating biomarkers in men with prostate cancerWendy Demark-Wahnefried, Soroush Rais-Bahrami, Renee A Desmond, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2012
Endoglin (CD105) contributes to platinum resistance and is a target for tumor-specific therapy in epithelial ovarian cancerAngela J Ziebarth, Somaira Nowsheen, Adam D Steg, et al.
Practical Radiation Oncology|June 2, 2023
Prostate Stereotactic Body Radiation Therapy With a Focal Simultaneous Integrated Boost: 5-Year Toxicity and Biochemical Recurrence Results From a Prospective TrialJared A Maas, Michael C Dobelbower, Eddy S Yang, et al.
Cancer|November 14, 2018
The antitumor effects of entinostat in ovarian cancer require adaptive immunityHaller J Smith, Tyler R McCaw, Angelina I Londono, et al.
Pageof 13